Feasibility of a Stroke Specific Self-management Program

Summary

Stroke is a leading cause of disability, institutionalization, readmission and death. This research is being completed to accelerate the adoption of evidence-based therapy practices that improve overall stroke care and outcomes. We will implement a feasibility randomized controlled trial (RCT) studying the implementation of a stroke specific chronic disease self-management program. Specifically, if the person is identified to have a chronic vision impairment identified on the vision screen, a specific low vision self-management program will be used. Otherwise the program that will be used is the generic chronic disease self-management program.

Conditions

• Stroke
• Chronic Conditions

Interventions

OTHER

Self- management program

The program sessions are either adapted from the Stanford Patient Education Research Center's program called the Chronic Disease Self-Management Program (CDSMP) or from a vision self-management program. Despite which self-management program, the format for each session will include, review of educational materials (using the CDSMP book/article), discussion via a case vignette (which is always stroke related), and participation in an activity based on that session's topic. These group sessions will be 1.5 hours each week for 6 weeks

OTHER

Standard care

All stroke patients being discharged from the acute hospital receive the following care: 1. 1 follow-up call within 2 weeks by a nurse coordinator. The call involves checking if medications were able to be filled and how the person is feeling. 2. A stroke clinic appointment that is set to occur 90-days post discharge. 3. A list of their personal medications and generic educational materials. The educational materials are standard forms located in the Epic system. It is the nurses' responsibility to choose what forms to provide, however it is mandatory that stroke risk factor information is included. 4. Information on local support groups. 5. Referrals to start physical, occupational or speech therapy, if recommended by their physician.

Sponsors & Collaborators

• National Center for Advancing Translational Sciences (NCATS)

  collaborator NIH

• The Claude D. Pepper Older Americans Independence Centers

  collaborator OTHER

• The University of Texas Medical Branch, Galveston

  lead OTHER

Principal Investigators

• Timothy Reistetter, PhD · University of Texas

Study Design

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2019-09-03

Primary Completion

2021-12-31

Completion

2022-12-31

Countries

• United States

Study Locations